Coronavirus: Hydroxychloroquine

Department of Health and Social Care written question – answered on 2nd April 2020.

Alert me about debates like this

Photo of Lord Alton of Liverpool Lord Alton of Liverpool Crossbench

To ask Her Majesty's Government what assessment they have made of reports about the success of using hydroxychloroquine to treat COVID-19, following a study carried out by Professor Raoult, director of the Institut Hospitalo-Universitaire de Marseille.

Photo of Lord Bethell Lord Bethell The Parliamentary Under-Secretary for Health and Social Care

The Department is considering carefully all available evidence around the potential of different medicines for use in treating COVID-19. Clinical trials are ongoing and being developed to assess the benefits of a number of different medicines in treating COVID-19.

Hydroxychloroquine is not currently licensed to treat COVID-19 related symptoms or prevent infection. Clinical trials are being established to test hydroxychloroquine as an agent in the treatment of COVID-19. These clinical trials are still not completed, so no conclusions have yet been reached on the safety and effectiveness of this medicine to treat or prevent COVID-19.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.